[DPHARMA] QoQ TTM Result on 30-Sep-2009 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
20-Nov-2009
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2009
Quarter
30-Sep-2009 [#3]
Profit Trend
QoQ- -6.04%
YoY- -21.24%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
Revenue 126,816 124,896 123,765 123,399 123,622 123,065 122,873 2.13%
PBT 34,460 35,638 38,215 33,217 35,047 34,863 35,340 -1.67%
Tax -7,251 -7,252 -7,981 -7,310 -7,476 -7,795 -7,938 -5.87%
NP 27,209 28,386 30,234 25,907 27,571 27,068 27,402 -0.47%
-
NP to SH 27,209 28,386 30,234 25,907 27,571 27,068 27,402 -0.47%
-
Tax Rate 21.04% 20.35% 20.88% 22.01% 21.33% 22.36% 22.46% -
Total Cost 99,607 96,510 93,531 97,492 96,051 95,997 95,471 2.87%
-
Net Worth 140,286 146,967 142,996 143,023 136,061 137,340 130,671 4.86%
Dividend
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
Div 22,910 16,743 16,743 9,814 9,814 20,833 20,833 6.55%
Div Payout % 84.20% 58.98% 55.38% 37.88% 35.60% 76.97% 76.03% -
Equity
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
Net Worth 140,286 146,967 142,996 143,023 136,061 137,340 130,671 4.86%
NOSH 138,897 138,648 138,831 138,857 138,837 138,727 139,011 -0.05%
Ratio Analysis
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
NP Margin 21.46% 22.73% 24.43% 20.99% 22.30% 21.99% 22.30% -
ROE 19.40% 19.31% 21.14% 18.11% 20.26% 19.71% 20.97% -
Per Share
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
RPS 91.30 90.08 89.15 88.87 89.04 88.71 88.39 2.18%
EPS 19.59 20.47 21.78 18.66 19.86 19.51 19.71 -0.40%
DPS 16.50 12.06 12.06 7.06 7.06 15.00 15.00 6.57%
NAPS 1.01 1.06 1.03 1.03 0.98 0.99 0.94 4.91%
Adjusted Per Share Value based on latest NOSH - 138,857
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
RPS 13.18 12.98 12.87 12.83 12.85 12.79 12.77 2.13%
EPS 2.83 2.95 3.14 2.69 2.87 2.81 2.85 -0.46%
DPS 2.38 1.74 1.74 1.02 1.02 2.17 2.17 6.36%
NAPS 0.1458 0.1528 0.1487 0.1487 0.1414 0.1428 0.1358 4.86%
Price Multiplier on Financial Quarter End Date
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
Date 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 -
Price 2.45 2.40 2.40 2.58 2.13 2.10 2.08 -
P/RPS 2.68 2.66 2.69 2.90 2.39 2.37 2.35 9.18%
P/EPS 12.51 11.72 11.02 13.83 10.73 10.76 10.55 12.06%
EY 8.00 8.53 9.07 7.23 9.32 9.29 9.48 -10.72%
DY 6.73 5.03 5.03 2.74 3.31 7.14 7.21 -4.50%
P/NAPS 2.43 2.26 2.33 2.50 2.17 2.12 2.21 6.54%
Price Multiplier on Announcement Date
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
Date 24/08/10 25/05/10 23/02/10 20/11/09 26/08/09 26/05/09 24/02/09 -
Price 2.45 2.38 2.33 2.49 2.50 2.34 2.20 -
P/RPS 2.68 2.64 2.61 2.80 2.81 2.64 2.49 5.03%
P/EPS 12.51 11.62 10.70 13.35 12.59 11.99 11.16 7.93%
EY 8.00 8.60 9.35 7.49 7.94 8.34 8.96 -7.29%
DY 6.73 5.07 5.18 2.84 2.82 6.41 6.82 -0.88%
P/NAPS 2.43 2.25 2.26 2.42 2.55 2.36 2.34 2.55%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment